Tryton Medical has announced the launch of its “Bifurcation Institute”, which it says is a comprehensive education resource that has been established to advance the standard of care for bifurcated coronary artery disease. Membership for the institute is free and provides physicians with access to e-newsletters that summarise recent clinical data and news.
A press release reports that Institute also provides links to timely webcasts and a case library that highlights the latest techniques and tips for treating bifurcation disease. Additionally, clinical symposia and educational workshops will available through the institute.
The press release adds that on 5–6 March 2014, Maciej Lesiak and his institution (Karol Marcinkowski, University of Medical Sciences, Poznan, Poland) will hold the inaugural Bifurcation Institute workshop, which will focus on the clinical outcomes and treatment of bifurcation lesions with the Tryton Side Branch Stent.
Lesiak said: “There is a significant unmet need for education and training regarding bifurcations. In patients undergoing PCI stenting, approximately one third has a bifurcation lesion. Left main disease is a persistent challenge in interventional cardiology, as more than 75% of left main lesions are bifurcation lesions. The Bifurcation Institute aims to evolve treatment patterns and current procedural guidance to incorporate safe and effective treatment of bifurcations in daily practice.”
The Bifurcation Institute features the results of the landmark Tryton IDE trial presented in a Late-breaking clinical trial session at TCT 2013.
